SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Roche Holding AG (RHHBY) trades at a trailing P/E of 26.7, forward P/E of 20.1. Trailing earnings yield is 3.74%, forward earnings yield 4.98%. PEG 0.56 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (46/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 20.1 (down from trailing 26.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.56 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 3.74% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 4.98% as earnings recover.
- Analyst consensus target $48.00 (-5.9% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 68/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
46/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — RHHBY
Valuation Multiples
P/E (TTM)26.7
Forward P/E20.1
PEG Ratio0.56
Forward PEG0.61
P/B Ratio0.00
P/S Ratio5.17
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.91
Forward EPS (Est.)$2.54
Book Value / Share$0.00
Revenue / Share$9.86
FCF / Share$0.00
Yields & Fair Value
Earnings Yield3.74%
Forward Earnings Yield4.98%
Dividend Yield0.00%
Analyst Target$48.00 (-5.9%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.39 |
$52.64B |
$9.58B |
18.2% |
| 2017 |
$1.25 |
$55.75B |
$8.63B |
15.5% |
| 2018 |
$1.53 |
$59.5B |
$10.5B |
17.6% |
| 2019 |
$1.95 |
$63.75B |
$13.5B |
21.2% |
| 2020 |
$2.07 |
$58.32B |
$14.3B |
24.5% |
| 2021 |
$2.03 |
$62.8B |
$13.93B |
22.2% |
| 2022 |
$1.94 |
$63.28B |
$12.42B |
19.6% |
| 2023 |
$1.79 |
$60.44B |
$11.5B |
19% |
| 2024 |
$1.29 |
$62.4B |
$8.28B |
13.3% |
| 2025 |
$1.91 |
$63.36B |
$12.88B |
20.3% |
